Corebridge Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,719
Closed -$318K 2883
2025
Q1
$318K Sell
26,719
-396
-1% -$5.4K ﹤0.01% 1823
2024
Q4
$397K Sell
27,115
-2,763
-9% -$38.6K ﹤0.01% 1802
2024
Q3
$375K Sell
29,878
-185
-0.6% -$2.02K ﹤0.01% 1885
2024
Q2
$256K Buy
+30,063
New +$268K ﹤0.01% 2052

Other funds holding ZYME

Corebridge Financial's ZYME Position: Q2 2025 in Review

Corebridge Financial sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 26,719 shares — an estimated $318K sold.

Corebridge Financial first reported a position in ZYME in Q2 2024 and held it in 4 quarters. The position peaked at $397K in Q4 2024. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Corebridge Financial reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 26,719 Zymeworks shares in Q2 2025, an estimated $318K.
  • Corebridge Financial first reported a position in Zymeworks in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Zymeworks position peaked at $397K in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.